Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954.

類似資料

• WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.
  著者:: See, D M, 等
  出版事項: (1993)
• In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
  著者:: Woods, M G, 等
  出版事項: (1989)
• Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.
  著者:: Turner, R B, 等
  出版事項: (1993)
• Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis.
  著者:: Anderson, D R, 等
  出版事項: (1996)
• Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.
  著者:: Gómez, R. M., 等
  出版事項: (1992)